SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
zhaoyaoshi
Lv3
300 积分
2023-08-25 加入
最近求助
最近应助
互助留言
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
3天前
已完结
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
5天前
已完结
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
5天前
已完结
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
5天前
已完结
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
8天前
已完结
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
8天前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
9天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
9天前
已完结
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
9天前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
9天前
已完结
没有进行任何应助
速度真快,点赞
3天前
帮大忙了,么么哒
5天前
速度真快,速度真快
5天前
点赞,速度真快
8天前
点赞,感谢
8天前
点赞,速度真快
9天前
速度真快,点赞
9天前
帮大忙了,速度真快
9天前
速度真快,点赞
9天前
点赞,速度真快,帮大忙了
9天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论